From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part one
 | Before treatment | 3th month of treatment | 5th month of treatment | p* |
---|---|---|---|---|
HGB | 12,11 ± 1,16 (12,08) | 12,20 ± 1,03 (12,05) | 12,38 ± 1,02 (12,31) | 0,027* |
HCT | 38,05 ± 3,19 (38,02) | 38,63 ± 3,45 (38,30) | 38,82 ± 2,81 (38,27) | 0,135 |
PLT | 350.932 ± 110.096 (334.600) | 310.671 ± 85.475 (309.850) | 303.202 ± 81.570 (296.700) | <0,001* |
SAA | 192,19 ± 295,14 (38,95) | 20,26 ± 46,58 (3,85) | 9,68 ± 25,81 (3,30) | <0,001* |
IRON | 53,47 ± 29,56 (50,85) | 66,76 ± 35,61 (56,50) | 67,41 ± 31,15 (64,00) | <0,001* |
TIBC | 361,09 ± 52,93 (362,50) | 364,78 ± 55,12 (365,00) | 372,91 ± 48,92 (366,00) | 0,163 |
FERRITIN | 56,63 ± 42,46 (45,00) | 34,69 ± 21,34 (30,55) | 32,74 ± 23,80 (25,55) | 0,002* |